Inhibition of PI3K leads to acute insulin resistance, blocking glucose uptake in skeletal muscle and adipose tissue, activating hepatic glycogenolysis, causing hyperglycemia and a compensatory increase in circulating insulin1,26,27. The gene discussed is PIK3CA; the disease is Hyperglycemia.